AC Immune (ACIU) Cash from Financing Activities (2015 - 2025)
AC Immune's Cash from Financing Activities came in at -$326,555 for the quarter ended Dec 31, 2025, compared with -$224,880 a year earlier.
Powered by 
Analysis
AC Immune (ACIU) Cash from Financing Activities (2015 - 2025) Analysis & Trends
For the year ended Dec 31, 2025, AC Immune's Cash from Financing Activities was -$1.23 million.
- Going back by year, Cash from Financing Activities was -$1.27 million in the year ended Dec 31, 2024, $48.16 million in the year ended Dec 31, 2023, -$1.41 million in the year ended Dec 31, 2022 and $44.59 million in the year ended Dec 31, 2021.
- The figure for the quarter ended Dec 31, 2025 represents the lowest quarterly Cash from Financing Activities since the quarter ended Sep 30, 2024.
- Business Quant data shows ACIU's Cash from Financing Activities at $205,018 (quarter ended Sep 30, 2025), -$298,349 (quarter ended Jun 30, 2025) and -$286,961 (quarter ended Mar 31, 2025) in the three quarters before the quarter ended Dec 31, 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | AC Immune | 266.56 Mn | 266.56 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -326,555.32 |
| Sep 30, 2025 | 205,017.96 |
| Jun 30, 2025 | -298,348.89 |
| Mar 31, 2025 | -286,960.64 |
| Dec 31, 2024 | -224,879.80 |
| Sep 30, 2024 | -3.63 Mn |
| Jun 30, 2024 | -68,559.20 |
| Mar 31, 2024 | -788,229.43 |
| Dec 31, 2023 | 46.25 Mn |
| Sep 30, 2023 | 507,204.35 |
| Jun 30, 2023 | 2.13 Mn |
| Mar 31, 2023 | -152,443.92 |
| Dec 31, 2022 | -156,741.31 |
| Sep 30, 2022 | -147,034.84 |
| Jun 30, 2022 | -142,246.14 |
| Mar 31, 2022 | -991,852.47 |
| Dec 31, 2021 | 31.16 Mn |
| Sep 30, 2021 | 4.71 Mn |
| Jun 30, 2021 | -20,836.30 |
| Mar 31, 2021 | 8.52 Mn |
API Access
AC Immune Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ACIU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "ACIU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ACIU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();